Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Alveograf
2. Calcitite
3. Calcium Hydroxyapatite
4. Durapatite
5. Hydroxyapatite, Calcium
6. Hydroxylapatite
7. Interpore 200
8. Interpore 500
9. Interpore-200
10. Interpore-500
11. Interpore200
12. Interpore500
13. Osprovit
14. Ossein Hydroxyapatite Compound
15. Ossein-hydroxyapatite Compound
16. Ossopan
17. Osteogen
18. Periograf
1. Durapatite
2. 12167-74-7
3. Hydroxylapatite
4. Alveograf
5. Periograf
6. Calcium Hydroxyapatite
7. Radiesse
8. Tribasic Calcium Phosphate
9. Durapatite [usan]
10. Calcium Hydroxide Phosphate
11. Win 40350
12. Calcium Hydroxylapatite
13. Calcium Hydroxide Tris(phosphate)
14. Pentacalcium;hydroxide;triphosphate
15. Hydroxylapatite, Ceramic
16. Ossopan
17. Calcium Phosphate, Tribasic [nf]
18. 91d9gv0z28
19. Durapatite (usan)
20. Mfcd00010904
21. Win-40350
22. Apatite, Hydroxy
23. Supertite 10
24. Calcium Phosphate, Tribasic (nf)
25. Pentacalcium Hydroxide Triphosphate
26. Hydroxylapatite (ca5(oh)(po4)3)
27. Calcium Orthophosphate, Basic
28. Hsdb 5804
29. Dekacalcium-dihydrat-hexa(phosphat)
30. Calcium Tribasic Phosphate
31. Einecs 215-145-7
32. Pentacalcium Monohydroxyorthophosphate
33. Pentacalcium Hydroxide Tris(orthophosphate)
34. Unii-91d9gv0z28
35. Hydroxyl Apatite
36. Alveograf (tn)
37. Decacalcium Hexaphosphate Dihydroxide
38. Einecs 235-330-6
39. Durapatite [mi]
40. Microcrystalline Hydroxyapatite Concentrate
41. Hydroxyapatite Nanopowder
42. Hydroxyapatite Micronpowder
43. Hydroxylapatite, Fast Flow
44. Calcarea Phosphorica
45. Ec 235-330-6
46. Hydroxyapatite Nanoparticles
47. Durapatite [who-dd]
48. Calcium Hydroxide Phosphate (ca10(oh)2(po4)6)
49. Hydroxyapatite [inci]
50. Hydroxyapatite [mart.]
51. Chembl2218916
52. Calcium Phosphate,tribasic
53. Calcium Orthophosphates Nanopowder
54. Dtxsid50872537
55. Hydroxylapatite, (ca 35-40%)
56. Calcarea Phosphorica [hpus]
57. Calcium Phosphate [who-ip]
58. Calcium Phosphate (tribasic)
59. Calcium Hydroxyapatite [inci]
60. Hydroxyapatite Nanoparticles Dispersion
61. Calcii Phosphas [who-ip Latin]
62. Tribasic Calcium Phosphate [ii]
63. Calcium Phosphate,tribasic [vandf]
64. Db-041626
65. Tribasic Calcium Phosphate [usp-rs]
66. Tribasic Calcium Phosphate [who-ip]
67. Ft-0630391
68. D03303
69. D03922
70. Calcium Phosphate Tribasic 34 To 40% Calcium Basis
71. J-004582
72. J-005837
73. Q27271399
74. Hydroxyapatite Nanoparticles, 5-10% (w/v) Aqueous Colloidal Dispersion, 20-50nm Particles
75. Pentacalcium Hydroxide Tris(orthophosphate), With A Fluorine Content Of Less Than 0,005 % By Weight On The Dry Anhydrous Product
Molecular Weight | 502.3 g/mol |
---|---|
Molecular Formula | Ca5HO13P3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 0 |
Exact Mass | 501.675955 g/mol |
Monoisotopic Mass | 501.675955 g/mol |
Topological Polar Surface Area | 260 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 36.8 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 9 |
EXPT USE: WOMEN WITH PRIMARY BILIARY CIRRHOSIS MALABSORB CALCIUM, PHOSPHATE & VITAMIN D, & DEVELOP ACCELERATED CORTICAL BONE THINNING. HYDROXYAPATITE WAS ASSESSED FOR ITS VALUE IN THE TREATMENT OF CORTICAL BONE THINNING IN PRIMARY BILIARY CIRRHOSIS. CORTICAL BONE LOSS OCCURRED IN THE CONTROL GROUP. THE HYDROXYAPATITE GROUP SHOWED A SIGNIFICANT GAIN IN CORTICAL BONE THICKNESS.
PMID:6287835 EPSTEIN O ET AL; AM J CLIN NUTR 36 (3): 426 (1982)
Biocompatible Materials
Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. (See all compounds classified as Biocompatible Materials.)
Market Place
ABOUT THIS PAGE
15
PharmaCompass offers a list of HYDROXYPROPYLMETHYLCELLULOSE API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier.
PharmaCompass also assists you with knowing the HYDROXYPROPYLMETHYLCELLULOSE API Price utilized in the formulation of products. HYDROXYPROPYLMETHYLCELLULOSE API Price is not always fixed or binding as the HYDROXYPROPYLMETHYLCELLULOSE Price is obtained through a variety of data sources. The HYDROXYPROPYLMETHYLCELLULOSE Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ossopan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ossopan, including repackagers and relabelers. The FDA regulates Ossopan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ossopan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ossopan supplier is an individual or a company that provides Ossopan active pharmaceutical ingredient (API) or Ossopan finished formulations upon request. The Ossopan suppliers may include Ossopan API manufacturers, exporters, distributors and traders.
click here to find a list of Ossopan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ossopan DMF (Drug Master File) is a document detailing the whole manufacturing process of Ossopan active pharmaceutical ingredient (API) in detail. Different forms of Ossopan DMFs exist exist since differing nations have different regulations, such as Ossopan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ossopan DMF submitted to regulatory agencies in the US is known as a USDMF. Ossopan USDMF includes data on Ossopan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ossopan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ossopan suppliers with USDMF on PharmaCompass.
A Ossopan CEP of the European Pharmacopoeia monograph is often referred to as a Ossopan Certificate of Suitability (COS). The purpose of a Ossopan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ossopan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ossopan to their clients by showing that a Ossopan CEP has been issued for it. The manufacturer submits a Ossopan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ossopan CEP holder for the record. Additionally, the data presented in the Ossopan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ossopan DMF.
A Ossopan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ossopan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ossopan suppliers with CEP (COS) on PharmaCompass.
Ossopan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ossopan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ossopan GMP manufacturer or Ossopan GMP API supplier for your needs.
A Ossopan CoA (Certificate of Analysis) is a formal document that attests to Ossopan's compliance with Ossopan specifications and serves as a tool for batch-level quality control.
Ossopan CoA mostly includes findings from lab analyses of a specific batch. For each Ossopan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ossopan may be tested according to a variety of international standards, such as European Pharmacopoeia (Ossopan EP), Ossopan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ossopan USP).